Mast Therapeutics, Inc. (NYSEMKT:MSTX) in last trading activity moved down -0.98% to close at $0.50. Company weekly performance is -8.18% while its quarterly performance stands at 14.77%. Mast Therapeutics, Inc. (NYSEMKT:MSTX) is -30.82% away from its 52 week high. Mast Therapeutics, Inc. (NYSEMKT:MSTX), reported financial results for the quarter ended March 31, 2015. The Company’s net loss for the first quarter of 2015 was $9.6 million, or $0.06 per share (basic and diluted), compared to a net loss of $6.4 million, or $0.06 per share (basic and diluted), for the same period in 2014.
On last trading day KeyCorp. (NYSE:KEY) moved down -0.14% to close at $14.72. Its volatility for the week is 1.90% while volatility for the month is 1.87%. KEY’s sales growth for past 5 years was -7.60% and its EPS growth for past 5 years was 19.70%. KeyCorp. (NYSE:KEY) monthly performance is 3.30%. KeyCorp (NYSE: KEY) announced that Don Kimble, Chief Financial Officer, along with E.J. Burke and Dennis Devine, Co-Presidents of Key Community Bank will present at the Deutsche Bank Global Financial Services Investor Conference in New York City on Tuesday, June 2, 2015, at 8:55 a.m. ET.
Fomento Economico Mexicano SAB (ADR) (NYSE:FMX) has 12.90% insider ownership while its institutional ownership stands at 39.20%. In last trading activity company’s stock closed at $93.78. RBC Capital upgraded shares of Fomento Economico Mexicano SAB (NYSE:FMX) from a neutral rating to an overweight rating in a report released on Thursday. RBC Capital currently has $51.00 price objective on the stock, down from their previous price objective of $54.00.
On Tuesday shares of Leidos Holdings, Inc. (NYSE:LDOS) closed at $39.63. Company’s sales growth for last 5 years was -13.70% and EPS growth for next 5 years is recorded as 8.00%. Leidos Holdings, Inc. (NYSE:LDOS), a national security, health and engineering solutions company, Tuesday said its first-quarter net income grew to $41 million from $37 million in the previous year. Earnings per share were $0.55, compared to $0.47 last year.
China Pharma Holdings, Inc. (NYSEMKT:CPHI) in last trading activity fell -12.54% to close at $0.34. Company weekly performance is -2.79% while its quarterly performance stands at 14.62%. China Pharma Holdings, Inc. (NYSEMKT:CPHI) is -39.09% away from its 52 week high. China Pharma Holdings, Inc. (NYSEMKT:CPHI) announced financial results for the quarter ended March 31, 2015. Revenue decreased 20% to $5.7 million in the first quarter of 2015 from $7.1 million in the first quarter of 2014.